Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
dexamethasone palmitate low-density lipoprotein complex
- Development stage
- Preclinical
- Lead developer
- Hokkaido College of Pharmacy
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Small Molecules
- Administration
- Intravenous
01
Overview
**Dexamethasone palmitate low-density lipoprotein complex** is an experimental LDL-based targeted drug-delivery system for atherosclerosis. It incorporates the lipophilic glucocorticoid prodrug dexamethasone palmitate into low-density lipoprotein particles to promote accumulation in atherosclerotic lesions. Following oxidative modification, the complex is taken up by macrophages and foam cells through scavenger-receptor-mediated pathways; released dexamethasone is intended to suppress cholesterol ester accumulation and foam-cell formation. In atherogenic mouse studies, intravenous DP-LDL complex reduced aortic cholesterol ester accumulation more potently than dexamethasone or dexamethasone-palmitate lipid emulsion comparators. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/14577972/))
- Other names
- DP-LDL complexdexamethasone palmitate (DP)-low density lipoprotein (LDL) complexdexamethasone palmitate-LDL complex
02
Targets
CD36 (CD36 antigen)GR (Glucocorticoid receptor)
Beyond the preview
Go deeper on dexamethasone palmitate low-density lipoprotein complex.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on dexamethasone palmitate low-density lipoprotein complex.